Biomedical Engineering Reference
In-Depth Information
[475] Torchilin VP. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
Adv Drug Delivery Rev 2008;60:548-58.
[476] Morris MC, Vidal P, Chaloin L, Heitz F, Divita G. A new peptide vector for effi-
cient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res 1997;25:
2730-6.
[477] Dalkara D, Zuber G, Behr JP. Intracytoplasmic delivery of anionic proteins. Mol Ther
2004;9:964-9.
[478] Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syndecan
adhesion molecules and powered by actin. J Gene Med 2004;6:769-76.
[479] Zelphati O, Wang Y, Kitada S, Reed JC, Felgner PL, Corbeil J. Intracellular delivery of
proteins with a new lipidmediated delivery system. J Biol Chem 2001;276:35103-10.
[480] Labat-Moleur F, Steffan AM, Brisson C, Perron H, Feugeas O, Furstenberger P, et al.
An electron microscopy study into the mechanism of gene transfer with lipopolyamines.
Gene Ther 1996;3:1010-17.
[481] Kaplan IM, Wadia JS, Dowdy SF. Cationic TAT peptide transduction domain enters
cells by macropinocytosis. J Control Release 2005;102:247-53.
[482] Ferrari A, Pellegrini V, Arcangeli C, Fittipaldi A, Giacca M, Beltram F. Caveolae-
mediated internalization of extracellular HIV-1 Tat fusion proteins visualized in real
time. Mol Ther 2003;8:284-94.
[483] Koutsokeras A, Kabouridis PS. Secretion and uptake of TAT-fusion proteins produced
by engineered mammalian cell. Biochim Biophys Acta 2009;1790:147-53.
[484] Potocky TB, Menon AK, Gellman SH. Cytoplasmic and nuclear delivery of a TAT-
derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J Biol Chem
2003;278:50188-94.
[485] Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MG, et al. Cell-
penetrating peptides a reevaluation of the mechanism of cellular uptake. J Biol Chem
2003;278:585-90.
[486] Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape
of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004;10:310-15.
[487] Belting M. Heparan sulfate proteoglycan as a plasma membrane carrier. Trends
Biochem Sci 2003;28:145-51.
[488] Fischer R, Köhler K, Fotin-Mleczek M, Roland BR. A stepwise dissection of the intra-
cellular fate of cationic cell-penetrating peptides. J Biol Chem 2004;279:12625-35.
[489] Console S, Marty C, Carlos García-Echeverría C, Schwendener R, Ballmer-Hofer K.
Antennapedia and HIV transactivator of transcription (TAT) “protein transduction
domains” promote endocytosis of high molecular weight cargo upon binding to cell sur-
face glycosaminoglycans. J Biol Chem 2003;278:35109-14.
[490] Antonio F, Aldo F, Monica Z, Caterina A, Vittorio P, Fabio B, et al. Cell membrane
lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. J Biol Chem
2003;278:34141-9.
[491] Ross MF, Filipovska A, Smith RA, Gait MJ, Murphy MP. Cell-penetrating peptides do
not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence
against direct passage through phospholipid bilayers. Biochem J 2004;383:457-68.
[492] Jing B, Zoran BP, Carlos B, Matthew K, Leonardo R, Marc SP. Effect of cell-based
intercellular delivery of transcription factor Gata4 on ischemic cardiomyopathy. Circ
Res 2007;100:1626-33.
[493] Toru O, Marjorie M, Alistair JW, Robert JS, Bruce JA, Stephen AD, et al. Cardiac-
specific deletion of GATA4 reveals its requirement for hypertrophy, compensation, and
myocyte viability. Circ Res 2006;98:837-45.
Search WWH ::
Custom Search